Increased Bookings Reinforce Novanta’s (NOVT) Broadening Organic Momentum

3 weeks ago 20

Soumya Eswaran

Thu, August 6, 2026 astatine 7:56 AM CDT 3 min read

Conestoga Capital Advisors, an plus absorption company, released its second-quarter 2026 capitalist letter. A transcript of the missive tin be downloaded here. The missive reports a affirmative marketplace displacement towards Small Caps, with the Russell 2000 Index achieving its champion archetypal fractional since 1991 and the Russell 2000 Growth Index up 25.7% successful Q2, fueled by AI enthusiasm and semiconductor stocks. However, marketplace enactment was uneven, mirroring the Tech Bubble, with high-beta stocks outperforming portion high-quality companies lagged, which impacted Conestoga's quality-focused strategies. Management expressed assurance successful semipermanent outcomes, noting that speculative enactment won't past arsenic monetary argumentation tightens and marketplace breadth improves. The steadfast remains committed to high-quality maturation businesses, expecting these to regain favour arsenic enactment broadens. The Conestoga Small Cap Composite returned 14.32% net-of-fees successful the 2nd quarter, with 25.71% for the Russell 2000 Growth Index. Narrow Index enactment wounded the comparative results, but it besides hid Composite improvements. In addition, delight cheque the Strategy's apical 5 holdings to cognize its champion picks successful 2026.

In its Q2 2026 capitalist letter, Conestoga Capital Advisors highlighted Novanta Inc. (NASDAQ:NOVT) arsenic a notable show contributor. Novanta Inc. (NASDAQ:NOVT) is simply a exertion solutions institution that offers precision medicine, precision manufacturing, aesculapian solutions, robotics and automation solutions, and precocious country solutions. On August 5, 2026, Novanta Inc. (NASDAQ:NOVT) closed astatine $153.12 per share, reflecting a marketplace capitalization of $5.45 billion. Novanta Inc. (NASDAQ:NOVT) posted a one-month instrumentality of 0.96%, portion its shares gained 34.63% implicit the past 52 weeks.

Conestoga Capital Advisors stated the following regarding Novanta Inc. (NASDAQ:NOVT) successful its Q2 2026 capitalist letter:

"Novanta Inc. (NASDAQ:NOVT) provides precision exertion solutions for aesculapian and precocious concern applications. The institution reported improving request crossed robotics, aesculapian technologies, semiconductor equipment, and AI-related applications, prompting absorption to rise its gross outlook. Bookings accrued 37% year-over-year, reinforcing assurance that integrated maturation is broadening crossed the portfolio."

Is Novanta Inc. (NOVT) the Best Scientific Instruments Stock to Buy Right Now?

Novanta Inc. (NASDAQ:NOVT) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 33 hedge money portfolios held Novanta Inc. (NASDAQ:NOVT) astatine the extremity of the archetypal quarter, compared to 38 successful the erstwhile quarter. While we admit the imaginable of Novanta Inc. (NASDAQ:NOVT) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article